Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filipe B Rodrigues

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Heart (British Cardiac Society)|June 4, 2015
Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysisDaniel Caldeira, Filipe B Rodrigues, Márcio Barra, et al.
Scientific Reports|March 11, 2018
Cerebrospinal fluid neurogranin and TREM2 in Huntington's diseaseLauren M Byrne, Filipe B Rodrigues, Eileanoir B Johnson, et al.
The European Journal of Neuroscience|January 29, 2019
Cerebrospinal fluid flow dynamics in Huntington's disease evaluated by phase contrast MRIFilipe B Rodrigues, Lauren M Byrne, Enrico De Vita, et al.
Neurology|May 12, 2017
Placebo and nocebo responses in restless legs syndrome: A systematic review and meta-analysisMaria A Silva, Gonçalo S Duarte, Raquel Camara, et al.
European Stroke Journal|April 23, 2019
Frequency of post-stroke electroencephalographic epileptiform activity - a systematic review and meta-analysis of observational studiesCarla Bentes, Filipe B Rodrigues, Diana Sousa, et al.
Acta Ophthalmologica|March 27, 2018
Efficacy and safety of intravitreal anti-tumour necrosis factor drugs in adults with non-infectious uveitis - a systematic reviewInês Leal, Filipe B Rodrigues, David Cordeiro Sousa, et al.
Brain Communications|November 16, 2022
Longitudinal evaluation of proton magnetic resonance spectroscopy metabolites as biomarkers in Huntington's diseaseAlexander J Lowe, Filipe B Rodrigues, Marzena Arridge, et al.
Journal of Neurochemistry|April 2, 2021
Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's diseaseFilipe B Rodrigues, Lauren M Byrne, Alexander J Lowe, et al.
The Lancet. Neurology|June 12, 2017
Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysisLauren M Byrne, Filipe B Rodrigues, Kaj Blennow, et al.
Neurology|January 26, 2018
Neurofilament light protein in blood predicts regional atrophy in Huntington diseaseEileanoir B Johnson, Lauren M Byrne, Sarah Gregory, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Heart (British Cardiac Society)|June 4, 2015
Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysisDaniel Caldeira, Filipe B Rodrigues, Márcio Barra, et al.
Scientific Reports|March 11, 2018
Cerebrospinal fluid neurogranin and TREM2 in Huntington's diseaseLauren M Byrne, Filipe B Rodrigues, Eileanoir B Johnson, et al.
The European Journal of Neuroscience|January 29, 2019
Cerebrospinal fluid flow dynamics in Huntington's disease evaluated by phase contrast MRIFilipe B Rodrigues, Lauren M Byrne, Enrico De Vita, et al.
Neurology|May 12, 2017
Placebo and nocebo responses in restless legs syndrome: A systematic review and meta-analysisMaria A Silva, Gonçalo S Duarte, Raquel Camara, et al.
European Stroke Journal|April 23, 2019
Frequency of post-stroke electroencephalographic epileptiform activity - a systematic review and meta-analysis of observational studiesCarla Bentes, Filipe B Rodrigues, Diana Sousa, et al.
Acta Ophthalmologica|March 27, 2018
Efficacy and safety of intravitreal anti-tumour necrosis factor drugs in adults with non-infectious uveitis - a systematic reviewInês Leal, Filipe B Rodrigues, David Cordeiro Sousa, et al.
Brain Communications|November 16, 2022
Longitudinal evaluation of proton magnetic resonance spectroscopy metabolites as biomarkers in Huntington's diseaseAlexander J Lowe, Filipe B Rodrigues, Marzena Arridge, et al.
Journal of Neurochemistry|April 2, 2021
Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's diseaseFilipe B Rodrigues, Lauren M Byrne, Alexander J Lowe, et al.
The Lancet. Neurology|June 12, 2017
Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysisLauren M Byrne, Filipe B Rodrigues, Kaj Blennow, et al.
Neurology|January 26, 2018
Neurofilament light protein in blood predicts regional atrophy in Huntington diseaseEileanoir B Johnson, Lauren M Byrne, Sarah Gregory, et al.
Pageof 7